Xconomy’s Digital Events →
December 3, 2020 · New York
Sigilon Therapeutics uses a capsule it developed to safely deliver engineered cells, which can deliver targeted protein therapeutics. Image courtesy of Sigilon.
Sponsored · Special Report
Hyperinflation in rents is over
Sponsored · Video
A Fireside Chat with Medpace's Regulatory Affairs Director David Horton
Sponsored · Whitepaper
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
© 2007-2020, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.